The storied success of sildenafil has undeniably shaped the drug landscape. However, putting money in companies heavily dependent on generic versions and the waning patent exclusivity surrounding this https://letusbookmark.com/story23347079/the-blue-pill-and-pharma-a-uncertain-opportunity